Diagnos Laboratorium Utama Tbk. vs Magna Investama Mandiri Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Magna Investama Mandiri Tbk. trades at Rp99 (market cap 351.35B, 11.97M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Magna Investama Mandiri Tbk. are close in size by market cap, and Magna Investama Mandiri Tbk. is more actively traded (11.97M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | MGNA | |
|---|---|---|
Market Cap | 319B | 351.35B |
Volume | 7.6K | 11.97M |
Lot | 76 | 119.74K |
Turnover | 1.74M | 1.26B |
Average Price | 229.21 | 105.4 |
Value | 1.74M | 1.26B |
Indicative Equilibrium Price | 232 | 107 |
Indicative Equilibrium Volume | 200 | 774 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Read more on MGNA →